It has been found that down-regulation of PRMT6 leads to up-regulation of p21 and p27, two members of the cyclin-dependent kinase (CDK) inhibitor CIP/KIP family, and accumulation of human osteosarcoma cell line U2OS at the G2 checkpoint. This evidence concerns the gene PRMT6 and osteosarcoma.